BridgeBio Pharma, Inc. Common Stock

BBIO us
$65.57
▼ 0.71 (-1.07%)
Volume: 1,998,852 · 2026-09-25

📈 Price Chart

Loading…
RSI (14)

🧭 Style Verdicts

🚀 Momentum 20
  • 21d momentum -17.4%
  • MA aligned bearish
  • RSI 28 oversold
🎯 Pullback 68
  • RSI 28 near lows
  • Near lower Bollinger band
  • -8.2% vs 20MA
💎 Value 58
  • -30% off 52w high

Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.

📐 Technicals

RSI(14)28.2
MACD-0.411
MA trendBearish
ATR4.08%
21d mom.-17.4%
63d mom.-6.7%
vs 20MA-8.2%
RVOL(20)0.77×
52w low · 50 52w high · 93
-29.8% from 52-week high
20d support 65 · resistance 81

Computed live from daily OHLCV · as of 2026-09-25

🏦 Fundamentals

Market cap$13.0B
PER—
PBR-5.15
PSR18.17
EPS$-3.54
ROE27.5%
ROA-56.8%
Dividend yield0.00%
Debt/Equity-0.98
EV/EBITDA-31.21
week1M3M6M1YYTD
-1.56% -17.39% -6.65% -9.66% +29.46% -16.19%

Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.

⚖️ AI Bull vs Bear

🐂 Bull
2/10
🐻 Bear
9/10

14d momentum -12.39%, daily vol 2.07%. BridgeBio Pharma, Inc. Common Stock sits in a bearish regime.

Derived from 14-day momentum and daily volatility on real OHLCV.

🗞 Related News

No recent news.